Seattle Genetics

Anything Can Happen This Year For Celldex
Anything Can Happen This Year For Celldex
Seeking Alpha
Celldex
breast cancer
CDX-110
CDX-111
Seattle Genetics
Flag link:
Five Super Ideas in the Healthcare Sector
Five Super Ideas in the Healthcare Sector
Motley Fool
Eli Lilly
Merck
Forest Labs
Regeneron
Seattle Genetics
Flag link:
Seattle Genetics Initiates Two Phase I Trials of SGN-CD19A
Seattle Genetics Initiates Two Phase I Trials of SGN-CD19A
Yahoo
Seattle Genetics
SGN-CD19A
acute lymphoblastic leukemia
non-Hodgkin B-cell lymphoma
Flag link:
4 Healthcare Stock Stories for TGIF Wellness
4 Healthcare Stock Stories for TGIF Wellness
Wall Street Cheat Street
Vertex Pharmaceuticals
Seattle Genetics
Echo Therapeutics
Santarus
Flag link:
Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Seeking Alpha
Arqule
Array Biopharma
Celldex
Aveo Pharmaceutical
Curis
Exelixis
MorphoSys
Genmab
Novartis
Incyte
Seattle Genetics
YM BioSciences
Flag link:
Biotech Corner: Monoclonal Antibody Companies
Biotech Corner: Monoclonal Antibody Companies
Seeking Alpha
monoclonal antibodies
Adcetris
Seattle Genetics
Progenics
Flag link:
Seattle Genetics to test possible new Adcetris use in late-stage study
Seattle Genetics to test possible new Adcetris use in late-stage study
Yahoo/AP
Seattle Genetics
Adcetris
non-Hodgkin's lymphoma
Flag link:
Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Data in CD30-Positive Non-Hodgkin Lymphomas and Other Malignancies from Multiple Presentations at ASH Annual Meeting
Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Data in CD30-Positive Non-Hodgkin Lymphomas and Other Malignancies from Multiple Presentations at ASH Annual Meeting
Yahoo/BusinessWire
Seattle Genetics
Adcetris
non-Hodgkin's lymphoma
Flag link:
Seattle Genetics: A Short Thesis That's Been Right And Wrong
Seattle Genetics: A Short Thesis That's Been Right And Wrong
TheStreet.com
Seattle Genetics
Flag link:
3 Things to Watch With Seattle Genetics
3 Things to Watch With Seattle Genetics
Motley Fool
Seattle Genetics
Flag link:
3 Things to Watch With Celldex Therapeutics
3 Things to Watch With Celldex Therapeutics
Motley Fool
Celldex
rindopepimut
CDX-011
Pfizer
Bristol-Myers Squibb
Amgen
Seattle Genetics
Flag link:
AstraZeneca Suspends The Buyback: Let The M&A Speculation Commence
AstraZeneca Suspends The Buyback: Let The M&A Speculation Commence
Seekin Alpha
M&A
AstraZeneca
Seattle Genetics
Regeneron
ONYX Pharmaceuticals
Biomarin
Forest Labs
Flag link:
PDL BioPharma CEO Explains Strategy To Maintain Dividend With Significant Growth
PDL BioPharma CEO Explains Strategy To Maintain Dividend With Significant Growth
Seeking Alpha
PDL Biopharma
Novartis
Seattle Genetics
Pfizer
JNJ
Eli Lilly
GSK
Bristol-Myers Squibb
Flag link:
2012 Biotech Stock Predictions: An Interim Report Card
2012 Biotech Stock Predictions: An Interim Report Card
TheStreet.com
Cell Therapeutics
Momenta
Onyx
Amag Pharmaceuticals
Biomarin
M&A
Celgene
Seattle Genetics
Galena Biopharma
ImmunoCellular
Amgen
Celldex
Dendreon
GSK
Vical
Oncothyreon
Biogen Idec
Merck KGaA
Bristol-Myers Squibb
Allos
Spectrum Pharmaceuticals
AstraZeneca
Flag link:
Six Disruptive Biotech Stocks
Six Disruptive Biotech Stocks
Motley Fool
Dendreon
Seattle Genetics
Immunogen
Roche
Vertex Pharmaceuticals
Aveo
Ariad Pharmaceuticals
Isis Pharmaceuticals
Flag link:
A Growth-Free Quarter -- and That's OK
A Growth-Free Quarter -- and That's OK
Motley Fool
Seattle Genetics
Flag link:
Seattle Genetics: A Growth-Free Quarter -- and That's OK
Seattle Genetics: A Growth-Free Quarter -- and That's OK
Motley Fool
Seattle Genetics
earnings
Flag link:
Bio Buyouts
Bio Buyouts
Motley Fool
Seattle Genetics
Alexion
Regeneron
Biomarin
Vertex Pharmaceuticals
Idenix
Obagi Medical Products
Flag link:
6 Biotech Stocks That Analysts Give The Green Light
6 Biotech Stocks That Analysts Give The Green Light
Seeking Alpha
GTx
Illumina
InterMune
QLT
Seattle Genetics
Vivus
Flag link:
Mid-Cap Biotech Stocks Accumulated By The World's Largest Money Managers
Mid-Cap Biotech Stocks Accumulated By The World's Largest Money Managers
Seeking Alpha
Alkermes
Medivation
Cubist Pharmaceuticals
Ariad Pharmaceuticals
Questcor Pharmaceuticals
Arena Pharmaceuticals
Seattle Genetics
Incyte
United Therapeutics
Amarin
ONYX Pharmaceuticals
Pharmacyclics
Human Genome Sciences
Theravance
Flag link:

Pages